The Use of PUL-042 Inhalation Solution to Reduce the Severity of COVID-19 in Adults Positive for SARS-CoV-2 Infection
Clinical trial NCT04312997 · COMPLETED
Trial details
- NCT number
- NCT04312997
- Sponsor
- Pulmotect, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-16
- Primary completion
- 2021-07-02
- Enrollment
- 101
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.